Nintedanib, a drug that helps prevent changes to lung tissue, may help patients with fibrosing autoimmune disease-related interstitial lung diseases (ILDs).
‘Nintedanib can significantly reduce the rate of decline in lung function in connective tissue disease–related ILDs characterized by progressive fibrosis.’
Read More..
In the trial, 170 patients with autoimmune disease-related ILDs were randomized to Nintedanib or placebo.Read More..
Investigators assessed patients' forced vital capacity (FVC), or the maximum amount of air one can forcibly exhale from the lungs after fully inhaling. (FVC is a predictor of mortality in patients with autoimmune disease-associated ILDs.)
The rate of decline in FVC over one year was -75.9 mL/year with Nintedanib versus -178.6 mL/year with placebo.
Autoimmune Inner Ear Disease Causes, Symptoms, Diagnosis and Treatment
Autoimmune inner ear disease is a condition that causes progressive deterioration of hearing and hearing loss. This is a serious condition that needs prompt medical attention.
Autoimmune inner ear disease is a condition that causes progressive deterioration of hearing and hearing loss. This is a serious condition that needs prompt medical attention.
"We now have a therapeutic approach that offers a strategy for reducing the morbidity associated with these diseases", said lead author Eric L. Matteson, MD, MPH, of the Mayo Clinic College of Medicine and Science.
Advertisement
Source-Medindia
